[ad_1]
|
Hearken to this text  |
Moon Surgical (Paris and San Francisco) introduced right this moment that it has raised $31.3 million in Sequence A funding to increase its staff and speed up the event of its Maestro robotic surgical procedure system.
GT Healthcare Capital & Companions led the spherical. There was additionally participation from Johnson & Johnson Innovation – JJDC, Cathay Well being — and present buyers together with Sofinnova Companions and medtech leaders together with Yann Fleureau, Siddarth Satish, Sacha Loiseau and Richard Leparmentier.
“At Moon Surgical, our ambition is to revolutionize minimally invasive surgical procedure by the ability of collaborative and adaptive robotics. Our Maestro System can be utilized in any laparoscopy, in any working room,” stated Anne Osdoit, CEO of Moon Surgical and a associate in Sofinnova Companions’ medtech accelerator, MD Begin.
“We’re excited to work with our new companions at GT Healthcare, Johnson & Johnson, and Cathay Well being as we enter the following stage of our firm’s evolution,” Osdoit stated in a information launch.
The 2-year-old firm stated it has early totally practical techniques and pushed by greater than 30 surgeons throughout two continents and a number of medical indications. The corporate’s purpose behind Maestro is to have a system that’s small, adaptable and built-in into present medical workflows.
“We share the imaginative and prescient of Maestro’s data-driven capabilities in underserved laparoscopic procedures, and hope to assist its path in making robotic surgical procedure accessible throughout all geographies,” stated Alan Au, managing associate of GT Healthcare. He’s becoming a member of Moon Surgical’s board.
Dr. Steve Oesterle, a former Medtronic SVP and enterprise associate at Cathay Well being, stated Maestro is about democratizing management throughout surgical procedure. “We’re all very desirous to assist this international enterprise in its growth in order that it could possibly quickly be utilized in many surgical procedures.”
Oesterle and Intuitive co-founder Dr. Fred Moll, chief growth officer of J&J’s Auris Well being, will function Moon Surgical board advisors.
[ad_2]
